EUVIMEDEUVIMED entdecken
Crossref

Phosphatidylcholine and Follistatin Revisited: Unveiling New Indications for These Panaceas in Human Health and Disease

Glen Alvin, Mike Chan

Japanese Journal of Medical Research · 2024

DOI: 10.33425/2993-6799.1014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Medical Research, 2024. Verfasst von Glen Alvin und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylcholine and follistatin, with their versatile and wide-ranging medical applications, have intrigued for more than 20 years [3]. They account for more than 50% of the total phospholipids in human cell membranes and up to 95% of the total choline pool in most tissues, playing a significant role in the structure and function of these membranes. Phosphatidylcholine, for instance, has made an impact as a lipid-lowering drug [1]. This drug has also effectively detected certain cancers, treated ulcerative colitis recalcitrant to empirical therapy, and steered osteoclast and osteoblast cells to prevent osteopenia and osteoporosis [2,3,8]. PC also aids in diagnosing and monitoring the treatment progress of Multiple sclerosis and sculpting the body via local subcutaneous lipolysis [10]. Follistatin, on the other hand, is a celebrated muscle builder and sexual libido enhancement and prevents bone and cartilage degeneration [16,17]. Its primary role is antagonising and neutralising the activity of transforming growth factor β (TGF-β) superfamily members [13]. Follistatin administration foils muscle diseases such as sarcopenia, and local subcutaneous follistatin injections decrease body weight and eliminate visceral fat [15,18]. Interestingly, natural plasma follistatin levels are elevated years before the onset of type 2 diabetes [13]. Follistatin maintains vascular health and offers a new treatment option for keloids [20,23].

Zitieren

APA

Alvin, G., & Chan, M. (2024). Phosphatidylcholine and Follistatin Revisited: Unveiling New Indications for These Panaceas in Human Health and Disease. Japanese Journal of Medical Research. https://doi.org/10.33425/2993-6799.1014

Vancouver

Alvin G, Chan M. Phosphatidylcholine and Follistatin Revisited: Unveiling New Indications for These Panaceas in Human Health and Disease. Japanese Journal of Medical Research. 2024. doi:10.33425/2993-6799.1014

BibTeX
@article{Alvin2024,
  author = {Alvin, Glen and Chan, Mike},
  title = {Phosphatidylcholine and Follistatin Revisited: Unveiling New Indications for These Panaceas in Human Health and Disease},
  journal = {Japanese Journal of Medical Research},
  year = {2024},
  doi = {10.33425/2993-6799.1014}
}
Kostenlos starten →